IN150 > Pill - white capsule/oblong
Pill with imprint IN150 > is White, Capsule/Oblong and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Watson Laboratories, Inc.
Ibandronate is used in the treatment of Prevention of Osteoporosis; Osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for IN150 >
Ibandronate Sodium
- Imprint
- IN150 >
- Strength
- 150 mg (base)
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
sorbitol,
microcrystalline cellulose,
silicon dioxide,
croscarmellose sodium,
sodium stearyl fumarate,
titanium dioxide,
magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-3770 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 42291-0336 (Discontinued) | AvKare, Inc. |
Related images for "IN150 >"
More about ibandronate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (120)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: bisphosphonates
- Breastfeeding
- En español
Patient resources
- Ibandronate oral/injection drug information
- Ibandronate (Intravenous) (Advanced Reading)
- Ibandronate (Oral) (Advanced Reading)
- Ibandronate Tablets
- Ibandronate Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.